Longevity Health Holdings Inc. Ordinary Shares XAGE 深 滬
等待開盤 07-18 09:30:00 美东时间
4.32
-1.460
-25.26%
華盛通- 最 高5.50
- 今 開5.36
- 成交量 60.50万股
- 最 低 4.26
- 昨 收 5.78
- 總市值 433.73万
- 52周最高 8.27
- 市盈率 靜 --
- 換手率 60.26%
- 52周最低 0.10
- 委 比 -71.43%
- 總股本 100.40万
- 歷史最高 13.3099
- 量 比 0.03
- 振 幅 21.45%
- 歷史最低 0.10
- 每 手 1
- 風險率
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Why Longevity Health Stock Is Skyrocketing Today
Longevity Health Holdings shares surge on Tuesday afternoon. The stock gained after announcing a merger with plasma collector True Health.
07-16 04:14
Market-Moving News for July 15th
TTD: 16% | The Trade Desk Will Replace Ansys In The S&P 500 Effective Prior To The Opening Of Trading On Friday, July 18 XAGE: 106% | Longevity Health Executes Definitive Merger Agreement With True
07-15 19:15
【美股盤前】銀行股業績開啟Q2財報季，恢復對華晶片出口的輝達大漲5%，蘋果投資提振稀土股MP漲14%，富國銀行跌2%
TradingKey - 7月15日週二美股盤前，投資人密切關註美國6月CPI通膨報告和銀行財報季。雖然預期CPI月率將創五個月以來最大可能打擊降息前景，但恢復H20晶片對華出口的輝達領漲大盤，標普500指數期貨漲0.42%，納斯達克100指數期貨漲0.65%。富國銀行二季度營收和利潤超預期，但對2025年淨利息收入的下調令WFC股價盤前跌超2%。受惠於交易業務強勁和投資銀行業務復甦，摩根大通二季度業績同樣超出預期，但JPM股價盤前依然下跌約0.50%，體現市場對金融股前景的謹慎情緒。
07-15 12:01
Longevity Health Executes Definitive Merger Agreement With True Health To Combine Companies In All-Stock Transaction; Longevity Announces Mutual Termination Of 20/20 Biolabs Transaction
Longevity Health Holdings, Inc. (NASDAQ:XAGE), a company focused on human longevity and healthy aging ("Longevity", the "Company", "we", "our", or "us"), today announced the execution of a definitive merger agreement
07-15 04:32
Longevity Health Holdings Announces Merger with THPlasma and Termination of 20/20 BioLabs Transaction
Longevity Health Holdings announced the execution of a definitive merger agreement with True Health Inc. (THPlasma) to combine the companies in an all-stock transaction. THPlasma, a leading player in the plasma collection industry, will merge with Longevity, which is focused on human longevity and healthy aging. The combined company will continue to trade on Nasdaq under the symbol “XAGE”. THPlasma has been rapidly expanding its plasma collect...
07-14 20:30
Longevity Health Extends Merger Due Diligence Deadline
Longevity Health Holdings ( ($XAGE) ) just unveiled an announcement. Longevity ...
06-26 05:32
Longevity Health Merger Agreement Deadline Extended To July 8, 2025; Merger Agreement To Terminate On July 8, 2025 If Not Extended
https://www.sec.gov/Archives/edgar/data/1842939/000095017025090015/xage-20250624.htm
06-26 05:10
Longevity Health Extends Strategic Partnership With Humana Through 2030 To Expand Special Needs Medicare Plan Offerings Across Skilled Nursing And Senior Living Facilities, With Plans For Multi-State Growth And Broader Member Reach
Agreement Expanded for Additional Five YearsPALM BEACH GARDENS, Fla., June 3, 2025 /PRNewswire/ -- Longevity Health, a clinical services company and national Institutional Special Needs Plan (ISNP), today announced that
06-03 23:19
Longevity Health Holdings Raises $1.96M Through ATM Equity Offering With Sale Of 479,621 Shares At Average Price Of $4.08 Per Share
Longevity Health Holdings, Inc. (NASDAQ:XAGE) ("XAGE," the "Company," "we" or "our"), a company dedicated to advancing human longevity and healthy aging through regenerative bio-aesthetics, diagnostics, and nutrition,
05-27 21:22
Longevity Health Holdings, Inc. Announces Successful Fundraising Via ATM Sale
Longevity Health Holdings, Inc. (XAGE) successfully sold 479,621 shares of its common stock at an average price of $4.08 per share through its at-the-market (ATM) equity offering, raising approximately $1.96 million in gross proceeds. This financing extends XAGE’s cash runway into Q1 FY26, assuming no growth beyond its pro forma FY24 sales and not factoring in the planned merger with 20/20. XAGE CEO Rajiv Shukla expressed confidence in the merger...
05-27 13:20
